Conmed Corp
NYSE:CNMD

Watchlist Manager
Conmed Corp Logo
Conmed Corp
NYSE:CNMD
Watchlist
Price: 36.64 USD -1.19% Market Closed
Market Cap: $1.1B

Conmed Corp
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Conmed Corp
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Conmed Corp
NYSE:CNMD
Research & Development
-$55.9m
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$2.1B
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Edwards Lifesciences Corp
NYSE:EW
Research & Development
-$1.1B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Stryker Corp
NYSE:SYK
Research & Development
-$1.6B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.9B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.3B
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-21%
No Stocks Found

Conmed Corp
Glance View

Conmed Corporation, founded in the small city of Utica, New York, has carved a niche for itself in the competitive world of medical technology. The company, which began its journey in the mid-1970s, has evolved into a global player by specializing in a variety of surgical and patient care products. At its core, Conmed thrives on its deep expertise in the design and manufacturing of surgical instruments used predominantly in minimally invasive procedures. These include sophisticated medical devices for orthopedic, laparoscopic, robotic, and general surgeries. Conmed’s strategic focus has always been on innovation, driven by a commitment to enhance the surgeon's ability to provide superior patient care, which is evident in their continuous research and development efforts aimed at creating more efficient and effective tools for medical professionals. The revenue streams for Conmed are as diversified as their product offerings. By selling advanced surgical equipment and medical products to hospitals, surgical centers, and outpatient facilities worldwide, Conmed positions itself as a critical supplier in the healthcare industry. A significant portion of their income is derived from the repeat sales of disposable items and replacement parts required for these high-tech devices. This creates a continuous cycle of revenue through both initial capital sales and recurring sales of consumables, quintessential for sustaining robust financial stability. Furthermore, the company's growth strategy has been marked by strategic acquisitions, allowing it to broaden its array of products and enter new markets, thereby ensuring its continued prominence and adaptability in the ever-evolving landscape of healthcare technology.

CNMD Intrinsic Value
84.44 USD
Undervaluation 57%
Intrinsic Value
Price

See Also

What is Conmed Corp's Research & Development?
Research & Development
-55.9m USD

Based on the financial report for Dec 31, 2025, Conmed Corp's Research & Development amounts to -55.9m USD.

What is Conmed Corp's Research & Development growth rate?
Research & Development CAGR 10Y
-7%

Over the last year, the Research & Development growth was -3%. The average annual Research & Development growth rates for Conmed Corp have been -6% over the past three years , -7% over the past five years , and -7% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett